SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-000583
Filing Date
2021-07-29
Accepted
2021-07-29 06:41:47
Documents
50
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q labp-20210630.htm   iXBRL 10-Q 1857211
2 EX-1.1 labp-20210630ex1_1.htm EX-1.1 537348
3 EX-31.1 labp-20210630ex31_1.htm EX-31.1 16304
4 EX-32.1 labp-20210630ex32_1.htm EX-32.1 9428
5 GRAPHIC img109913962_0.jpg GRAPHIC 83651
  Complete submission text file 0000950170-21-000583.txt   6917620

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT labp-20210630_cal.xml EX-101.CAL 35358
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT labp-20210630.xsd EX-101.SCH 32841
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT labp-20210630_pre.xml EX-101.PRE 227715
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT labp-20210630_def.xml EX-101.DEF 100321
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT labp-20210630_lab.xml EX-101.LAB 343360
11 EXTRACTED XBRL INSTANCE DOCUMENT labp-20210630_htm.xml XML 1068186
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Filer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39971 | Film No.: 211124728
SIC: 2834 Pharmaceutical Preparations